Back to search

Pulmobiomed Ltd

12552857

active
Private Limited Company
england wales
Companies House
Health Score
88 / 100

Healthy

30/30
Filing
20/30
Financial
38/40
Risk
  • 1 outstanding charge (-2)

Details

RMT ACCOUNTANTS & BUSINESS ADVISORS LTD, NEWCASTLE UPON TYNE, NE12 8EG
Incorporated 09/04/2020

Compliance

Last accounts

30/04/2025

total exemption full

Next accounts due

31/01/2027

On track

Confirmation statement

Last: 12/06/2025

Due 26/06/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Sterghios Moschos

director · Since 09/04/2020

ASSOCIATE PROFESSOR

GREEK · UNITED KINGDOM · Age 47

Mr David Pope

secretary · Since 18/01/2024

Professor Sir Peter John Barnes

director · Since 18/01/2024

PROFESSOR OF THORACIC MEDICINE

BRITISH · ENGLAND · Age 79

Also on 2 other boards

Mr Mark Jeremy Sanders

director · Since 18/01/2024

RETIRED, PART-TIME CONSULTANT

BRITISH · ENGLAND · Age 69

Also on 4 other boards

Mr Trevor Michael Phillips

director · Since 27/05/2025

DIRECTOR

BRITISH · ENGLAND · Age 65

Also on 2 other boards

Persons with Significant Control

Dr Sterghios Moschos

25–50% shares

Greek · United Kingdom · Age 47

Rmt Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle Upon Tyne, NE12 8EG

Notified 09/04/2020

University Of Northumbria At Newcastle

25–50% shares

Sutherland Building, Northumbria University, Newcastle Upon Tyne, NE1 8ST

Notified 02/12/2020

Charges1 outstanding

Charge
outstanding

ENTERPRISE VENTURES (GENERAL PARTNER NE VENTURE) LIMITED (AS ORIGINAL SECURITY TRUSTEE)

Created 31/03/2025Registered 03/04/2025

CompanyRankvs 817+ SIC 72110 peers
56

Financial strength88th percentile among SIC peers · 22/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 5.69× · 20/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
817Pulmobiomed Ltd
66
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/04/2025

Net Worth

£405k

Balance sheet strength

Cash

£741k

Cash in the bank

Net Current Assets

£812k

Working capital

Current Assets

£985k

Current Liabilities

£173k

Fixed Assets

£173k

Debtors

£244k

0avg. employees-4

Balance Sheet

Assets less current liabilities£985k
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20255.69-£745k
202413.14+£1.3M
20231.57-£72k
20224.05-£29k
20215.10—

Derived from filed accounts. Not audited figures.